Schedule 13D ownership disclosure

PetLife Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 71639B105

Event date: 2014-09-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,915,944
Percent of class
8.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001360865-14-000049
Form type
SC 13D
Filer
Langley Richard H.
CIK
CIK 1215323
Filed
Sep 29, 2014
Reporting period
Sep 15, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub